Matches in Wikidata for { <http://www.wikidata.org/entity/Q62813167> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- Q62813167 description "clinical trial" @default.
- Q62813167 description "ensayu clínicu" @default.
- Q62813167 description "klinisch onderzoek" @default.
- Q62813167 description "клінічне випробування" @default.
- Q62813167 description "临床试验" @default.
- Q62813167 name "A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF" @default.
- Q62813167 type Item @default.
- Q62813167 label "A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF" @default.
- Q62813167 prefLabel "A Phase 2 Study to Evaluate the Safety, Biological Activity, and PK of ND-L02-s0201 in Subjects With IPF" @default.
- Q62813167 P1050 Q62813167-127D3BE9-AC3B-4175-959D-C75BAC84172B @default.
- Q62813167 P1050 Q62813167-1E3DB492-5F15-4B3A-B07D-2E406886556B @default.
- Q62813167 P1132 Q62813167-C43A468D-C83D-4487-8FE4-4E34EAD5FA77 @default.
- Q62813167 P1476 Q62813167-C588DF04-15B5-42C2-A7A5-1CC975BE4B39 @default.
- Q62813167 P17 Q62813167-02B2A210-26C5-4524-B5C7-58101D5FCCD5 @default.
- Q62813167 P17 Q62813167-8C91559E-C6B2-4E83-A76D-35702D4B435B @default.
- Q62813167 P2899 Q62813167-EA847BCC-05F6-409B-89E7-2C33167DB5E2 @default.
- Q62813167 P3098 Q62813167-10E06491-446B-4BB2-8D89-78BD0A9E7C53 @default.
- Q62813167 P31 Q62813167-85FC410D-41E8-466D-8243-8C8B4623E04D @default.
- Q62813167 P4135 Q62813167-9A610A76-9134-4B65-BBA4-A13FB199DBF5 @default.
- Q62813167 P580 Q62813167-83E00D0D-1E4D-451A-89CA-41BE9DF37080 @default.
- Q62813167 P582 Q62813167-51BF22C3-5EC7-4722-AB1F-CC40384D5B66 @default.
- Q62813167 P6099 Q62813167-CED2B085-C307-48AC-9A4E-74EFE1F62D09 @default.
- Q62813167 P6153 Q62813167-2CAA0206-8A7B-409D-A233-085580987D75 @default.
- Q62813167 P6153 Q62813167-5BB5B379-96D5-4019-A87E-ED809D078CD3 @default.
- Q62813167 P6153 Q62813167-7A475F41-7F3C-477C-A6FD-6830DB794B3C @default.
- Q62813167 P6153 Q62813167-A9142A9E-CC7B-42EE-A694-97EB0E546E06 @default.
- Q62813167 P6153 Q62813167-AF3D1F26-3271-457C-BB4B-0DC738D3470E @default.
- Q62813167 P6153 Q62813167-C37121F8-A785-4933-BA1A-904FD6BA7E44 @default.
- Q62813167 P6153 Q62813167-C9535233-A880-4148-8E7B-DFDFB77B1DF8 @default.
- Q62813167 P6153 Q62813167-D0BC9B16-BF6F-43EE-B618-F86A9D57EFA5 @default.
- Q62813167 P6153 Q62813167-FACADC8A-A6CF-4409-923B-94482148065C @default.
- Q62813167 P6153 Q62813167-FC710543-742F-431D-8123-C9CAC9A71B04 @default.
- Q62813167 P8005 Q62813167-69C41B10-F18F-4970-9EF5-39DF2EC6A6E7 @default.
- Q62813167 P8363 Q62813167-9866318A-6395-4C2C-9C7C-8CE1CCC1EE17 @default.
- Q62813167 P859 Q62813167-15366D29-329F-4493-BDA6-201D1F9C5F2F @default.
- Q62813167 P1050 Q2290446 @default.
- Q62813167 P1050 Q32446 @default.
- Q62813167 P1132 "+120" @default.
- Q62813167 P1476 "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)" @default.
- Q62813167 P17 Q145 @default.
- Q62813167 P17 Q30 @default.
- Q62813167 P2899 "+40" @default.
- Q62813167 P3098 "NCT03538301" @default.
- Q62813167 P31 Q30612 @default.
- Q62813167 P4135 "+80" @default.
- Q62813167 P580 "2018-06-18T00:00:00Z" @default.
- Q62813167 P582 "2020-03-01T00:00:00Z" @default.
- Q62813167 P6099 Q42824440 @default.
- Q62813167 P6153 Q1052562 @default.
- Q62813167 P6153 Q1130172 @default.
- Q62813167 P6153 Q126412 @default.
- Q62813167 P6153 Q2725999 @default.
- Q62813167 P6153 Q5312894 @default.
- Q62813167 P6153 Q621043 @default.
- Q62813167 P6153 Q6694611 @default.
- Q62813167 P6153 Q6806451 @default.
- Q62813167 P6153 Q7063709 @default.
- Q62813167 P6153 Q911561 @default.
- Q62813167 P8005 Q76649708 @default.
- Q62813167 P8363 Q78089383 @default.
- Q62813167 P859 Q763637 @default.